The European Commission has approved Erbitux (cetuximab) in combination with [...]

FORE Biotherapeutics has completed target enrolment in the primary central [...]

The European Commission has approved BRAFTOVI in combination with cetuximab [...]

Pierre Fabre Laboratories has received a positive opinion from the [...]

N4 Pharma has reported new data from its collaboration with [...]

Tyra Biosciences has dosed the first child in BEACH301, its [...]

Landmark debt deal enables commercial readiness for ITM-11, supports pipeline [...]

SOTIO’s lead candidate, SOT109, is generating buzz in the ADC [...]